This is a preview of subscription content, log in via an institution to check access.
Reference
Due OT, et al. Cost-Utility Analysis of Direct-Acting Antivirals for Treatment of Chronic Hepatitis C Genotype 1 and 6 in Vietnam. Value in Health : 20 Jul 2020. Available from: URL: https://doi.org/10.1016/j.jval.2020.03.018
Rights and permissions
About this article
Cite this article
DAAs for chronic hepatitis C: good public health investment in Vietnam. PharmacoEcon Outcomes News 859, 11 (2020). https://doi.org/10.1007/s40274-020-7020-1
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-020-7020-1